Assyro AI

FDA Orange Book · active-ingredient family

Estazolam

Estazolam is approved as 1 brand and 3 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:PROSOM · NDA 019080

1

Brand (NDA)

3

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · tablet

ProductApplicantApplicationTEApproved
PROSOMRLD×2ABBOTTNDA 019080Dec 26, 1990

Generic (ANDA) products (3)

ProductApplicantApplicationTEApproved
ESTAZOLAM×2WATSON LABSANDA 074818ABAug 19, 1997
ESTAZOLAM×2DR REDDYS LABS SAANDA 074921ABJul 10, 1997
ESTAZOLAM×2NOVITIUM PHARMAANDA 074826ABJul 03, 1997

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Estazolam — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.